Literature DB >> 6589016

Prostaglandins in menstrual fluid in menorrhagia and dysmenorrhoea.

M C Rees, A B Anderson, L M Demers, A C Turnbull.   

Abstract

Menstrual fluid was collected in vaginal cups inserted for 2 h during the first 2 days of menstruation and menstrual serum concentrations of prostaglandins PGF2 alpha and PGE2 were measured by radioimmunoassay. In 16 women from whom menstrual fluid was collected on both days, PGF2 alpha and PGE2 concentrations were significantly higher on day 1 than on day 2. The highest concentrations of PGF2 alpha and PGE2 were found in dysmenorrhoeic women on day 1. In non-dysmenorrhoeic women, the amount of PGF2 alpha and PGE2 collected in 2 h correlated directly with total menstrual blood loss. There was no statistically significant difference in the amount of prostaglandins collected in 2 h in pain-free menorrhagic women and dysmenorrhoeic women with normal loss. There was also no significant 9-ketoreductase or 9-hydroxydehydrogenase activity present in menstrual fluid which could suggest PGE2 to PGF2 alpha interconversion.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6589016     DOI: 10.1111/j.1471-0528.1984.tb04829.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  12 in total

1.  Stress and dysmenorrhoea: a population based prospective study.

Authors:  L Wang; X Wang; W Wang; C Chen; A G Ronnennberg; W Guang; A Huang; Z Fang; T Zang; L Wang; X Xu
Journal:  Occup Environ Med       Date:  2004-12       Impact factor: 4.402

2.  Menorrhagia.

Authors:  M Rees
Journal:  Br Med J (Clin Res Ed)       Date:  1987-03-21

3.  Menstrual pain and epithelial ovarian cancer risk.

Authors:  Ana Babic; Daniel W Cramer; Linda J Titus; Shelley S Tworoger; Kathryn L Terry
Journal:  Cancer Causes Control       Date:  2014-09-05       Impact factor: 2.506

Review 4.  A contemporary approach to dysmenorrhea in adolescents.

Authors:  Zeev Harel
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 5.  Chronic pelvic pain and endometriosis: translational evidence of the relationship and implications.

Authors:  Pamela Stratton; Karen J Berkley
Journal:  Hum Reprod Update       Date:  2010-11-23       Impact factor: 15.610

6.  Measuring menstrual discomfort: a comparison of interview and diary data.

Authors:  Anne Marie Zaura Jukic; Clarice R Weinberg; Donna D Baird; Paige P Hornsby; Allen J Wilcox
Journal:  Epidemiology       Date:  2008-11       Impact factor: 4.822

Review 7.  Exercise and primary dysmenorrhoea : a comprehensive and critical review of the literature.

Authors:  Amanda J Daley
Journal:  Sports Med       Date:  2008       Impact factor: 11.136

Review 8.  Risk-benefit assessment of drugs used for the treatment of menstrual disorders.

Authors:  J M Higham; R W Shaw
Journal:  Drug Saf       Date:  1991 May-Jun       Impact factor: 5.606

9.  Menstrual pain and risk of epithelial ovarian cancer: Results from the Ovarian Cancer Association Consortium.

Authors:  Ana Babic; Holly R Harris; Allison F Vitonis; Linda J Titus; Susan J Jordan; Penelope M Webb; Harvey A Risch; Mary Anne Rossing; Jennifer A Doherty; Kristine Wicklund; Marc T Goodman; Francesmary Modugno; Kirsten B Moysich; Roberta B Ness; Susanne K Kjaer; Joellen Schildkraut; Andrew Berchuck; Celeste L Pearce; Anna H Wu; Daniel W Cramer; Kathryn L Terry
Journal:  Int J Cancer       Date:  2017-09-21       Impact factor: 7.396

10.  EP2 receptor mediated cAMP release is augmented by PGF 2 alpha activation of the FP receptor via the calcium-calmodulin pathway.

Authors:  A B Abera; K J Sales; R D Catalano; A A Katz; H N Jabbour
Journal:  Cell Signal       Date:  2009-09-25       Impact factor: 4.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.